You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

maximal tolerated dose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in Beijing (B7-H3-targeting CAR-T cells)

Recruiting
  • Glioblastoma
  • B7-H3-targeting CAR-T cells
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Feb 11, 2022

Quality of Life Trial in Newcastle (Leg Press Resistance Training Machine)

Completed
  • Quality of Life
  • Leg Press Resistance Training Machine
  • Newcastle, Tyne And Wear, United Kingdom
    Nortuhmbria University
Oct 24, 2023

Pain, Postoperative, Depression, Postpartum Trial in Pittsburgh (Dose Level 1, Dose Level 2, Dose Level 3)

Not yet recruiting
  • Pain, Postoperative
  • Depression, Postpartum
  • Dose Level 1
  • +3 more
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital of UPMC
Jun 7, 2023

Quality of Life Trial in Newcastle (Leg Press Resistance Training (3x5), Leg Press Resistance Training (5x5))

Recruiting
  • Quality of Life
  • Leg Press Resistance Training (3x5)
  • Leg Press Resistance Training (5x5)
  • Newcastle, Tyne And Wear, United Kingdom
    Northumbria University
Nov 6, 2023

Advanced Solid Tumors Trial in Huntersville, Cleveland (2X-121 and dovitinib)

Recruiting
  • Advanced Solid Tumors
  • 2X-121 and dovitinib
  • Huntersville, North Carolina
  • +1 more
Feb 1, 2023

Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

Not yet recruiting
  • Multiple Myeloma
  • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
  • +3 more
  • (no location specified)
Jul 28, 2023

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

Amyotrophic Lateral Sclerosis Trial in Hualien City (HK-001, Placebo control)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis
  • Hualien City, Taiwan
    Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Jan 16, 2023

HPV-Related Carcinoma Trial (IBRX-042)

Not yet recruiting
  • HPV-Related Carcinoma
  • (no location specified)
Jul 26, 2023

Basal Cell Carcinoma Trial in Aventura (Placebo-containing MNA, 25 µg doxorubicin-containing MNA, 50 µg doxorubicin-containing

Terminated
Has Results
  • Basal Cell Carcinoma
  • Placebo-containing MNA
  • +4 more
  • Aventura, Florida
    The Center for Clinical and Cosmetic Research
Aug 16, 2022

Relapsed/Refractory Diffuse Large B-cell Lymphoma and Multiples Myeloma Trial in Dresden (MDC-CAR-BCMA001 (BCMA directed CAR

Not yet recruiting
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma and Multiples Myeloma
  • MDC-CAR-BCMA001 (BCMA directed CAR T-cells)
  • Dresden, Germany
    Technische Universität Dresden, NCT/UCC, Early Clinical Trial Un
Apr 19, 2023

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • (no location specified)
Aug 7, 2023

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Advanced Solid Tumors Trial in Guangzhou (MR001)

Not yet recruiting
  • Advanced Solid Tumors
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Nov 12, 2023

Solid Tumor, KRAS Mutation Trial (BI 3706674)

Not yet recruiting
  • Solid Tumor, KRAS Mutation
  • BI 3706674
  • (no location specified)
Sep 29, 2023

Healthy Trial (BI 3032950, Placebo matching BI 3032950)

Not yet recruiting
  • Healthy
  • BI 3032950
  • Placebo matching BI 3032950
  • (no location specified)
Aug 3, 2023

Glioma Trial (BI 764532)

Not yet recruiting
  • Glioma
  • BI 764532
  • (no location specified)
Jun 15, 2023

Healthy Trial in Glendale (ALN-PNP, Placebo (PB))

Recruiting
  • Healthy
  • Glendale, California
    California Clinical Trials Medical Group
Jan 31, 2023

Colon Cancer Stage I Trial in Taoyuan (Magicell-NK contains NK cells suspended in 100 mL normal saline)

Recruiting
  • Colon Cancer Stage I
  • Magicell-NK contains NK cells suspended in 100 mL normal saline
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou
Sep 28, 2022

Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Neuroendocrine Neoplasms
  • BI 764532
  • +3 more
  • (no location specified)
Nov 10, 2023

Healthy Trial (PF-07976016, Placebo, Midazolam)

Not yet recruiting
  • Healthy
  • (no location specified)
Oct 24, 2023

Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)

Recruiting
  • Sarcoma, Clear Cell
  • CPI-613 + Hydroxychloroquine
  • Duarte, California
  • +7 more
Nov 10, 2022

Nonalcoholic Steatohepatitis, Genetic Risk Factor Trial (ALN-PNP Dose Level 1, ALN-PNP Dose Level 2, ALN-PNP Dose Level 3)

Not yet recruiting
  • Nonalcoholic Steatohepatitis
  • Genetic Risk Factor
  • ALN-PNP Dose Level 1
  • +3 more
  • (no location specified)
Sep 5, 2023

Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin Trial in Ann Arbor (Bortezomib, Ruxolitinib)

Completed
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
Dec 3, 2021

MuSK Myasthenia Gravis Trial (MuSK-CAART)

Not yet recruiting
  • MuSK Myasthenia Gravis
  • MuSK-CAART
  • (no location specified)
Jul 5, 2022